Newsadmin2025-04-07T10:16:14+00:00

News

hTERT immortalized ASC for large-scale EV production

hTERT immortalized ASC for large-scale EV production

Giulia Corso2024-05-29T13:40:27+00:00May 23rd, 2024|

Evercyte proudly introduces the EVscale™ platform

Evercyte proudly introduces the EVscale™ platform

Giulia Corso2024-09-26T11:29:18+00:00April 29th, 2024|

Newly published study featuring our PODO/TERT256 cell line

Newly published study featuring our PODO/TERT256 cell line

Giulia Corso2024-09-26T11:49:21+00:00February 16th, 2024|

Evercyte contributing to reduce animal testing at key events

Evercyte contributing to reduce animal testing at key events

Giulia Corso2024-09-26T11:29:37+00:00December 7th, 2023|

Evercyte Showcases Expertise in Japan’s Pharma Landscape

Evercyte Showcases Expertise in Japan’s Pharma Landscape

Giulia Corso2024-09-26T11:30:10+00:00November 22nd, 2023|

Participation to the first MOVE symposium

Participation to the first MOVE symposium

Giulia Corso2024-09-26T11:30:28+00:00October 27th, 2023|

Previous 345 Next